Detalhe da pesquisa
1.
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.
Cell
; 163(5): 1237-1251, 2015 Nov 19.
Artigo
Inglês
| MEDLINE | ID: mdl-26590425
2.
Regulations of Tumor Microenvironment by Prostaglandins.
Cancers (Basel)
; 15(12)2023 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37370700
3.
Sensing plasma membrane pore formation induces chemokine production in survivors of regulated necrosis.
Dev Cell
; 57(2): 228-245.e6, 2022 01 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35016014
4.
Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
Int J Cancer
; 124(7): 1545-51, 2009 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19089921
5.
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
Nat Commun
; 10(1): 3055, 2019 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31296870
6.
Role of Rho GTPases in breast cancer.
Front Biosci
; 13: 759-76, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17981586
7.
Impairment of mitochondrial respiration in mouse fibroblasts by oncogenic H-RAS(Q61L).
Cancer Biol Ther
; 9(2): 122-33, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19923925
8.
Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.
Cancer Res
; 68(1): 115-21, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18172303
9.
Cyclooxygenases, prostanoids, and tumor progression.
Cancer Metastasis Rev
; 26(3-4): 525-34, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17763971
10.
Human pregnane X receptor and resistance to chemotherapy in prostate cancer.
Cancer Res
; 67(21): 10361-7, 2007 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17974979